Loading...

YieldMax Strategic Metals & Mining Portfolio Option Income ETF

MINYβ€’AMEX
NaN
NaN
$46.06
$-1.05(-2.23%)
U.S. Market is Open β€’ 09:49

MINY News Today: Stay Updated with the Latest YieldMax Strategic Metals & Mining Portfolio Option Income ETF News in Real Time

Find MINY news now at Meyka AI. Stay informed with the latest YieldMax Strategic Metals & Mining Portfolio Option Income ETF stocks updates, including price news, market analysis, and expert insights.

IFX.DE Stock Gains 2.47% on XETRA; Infineon at €49.18
πŸ“… in about 5 hours

IFX.DE Stock Gains 2.47% on XETRA; Infineon at €49.18

IFX.DE stock rises 2.47% to €49.18 on XETRA. Infineon Technologies AG shows mixed signals with B- rating and upcoming earnings on May 6.

Read more
MLEC Insider Filing: Core Daniel Joaquin Director Stake, April 22, 2026
πŸ“… in about 5 hours

MLEC Insider Filing: Core Daniel Joaquin Director Stake, April 22, 2026

Director Core Daniel Joaquin files initial ownership of 933 ordinary shares in Moolec Science (MLEC) valued at $6,661.62 on April 15, 2026.

Read more
Canadian Flight Prices Jump April 22: Fuel Crisis Hits Travelers
πŸ“… in about 5 hours

Canadian Flight Prices Jump April 22: Fuel Crisis Hits Travelers

Canadian flight prices rise 2.9% in March 2026 for the first time in 2 years amid fuel crisis and baggage fee hikes.

Read more
DW8.AX Stock Surges 2400% in April 2026 on ASX
πŸ“… in about 5 hours

DW8.AX Stock Surges 2400% in April 2026 on ASX

DW8.AX stock price hits A$0.025 with massive 2400% gain. Beverage tech platform shows extreme volatility on ASX.

Read more
PASHUPATI.NS Stock Plunges 14.5% on NSE; Textile Maker Hits 22 Apr Close
πŸ“… in about 5 hours

PASHUPATI.NS Stock Plunges 14.5% on NSE; Textile Maker Hits 22 Apr Close

PASHUPATI.NS stock fell 14.5% to INR 81.95 on NSE today. Pashupati Cotspin faces strong sell rating with weak technical signals.

Read more
Travere Kidney Drug Approved April 22: FDA Flexes Authority
πŸ“… in about 5 hours

Travere Kidney Drug Approved April 22: FDA Flexes Authority

Travere’s Filspari approved by FDA April 22 for rare kidney disease, opening a $3B market opportunity despite limited efficacy data.

Read more
SO Stock: Morgan Stanley Maintains Underweight Rating April 2026
πŸ“… in about 5 hours

SO Stock: Morgan Stanley Maintains Underweight Rating April 2026

Morgan Stanley maintains Underweight rating on Southern Company (SO), lowering price target to $92 from $94 on April 21, 2026.

Read more
ABBN.SW Stock Surges 2.96% on Earnings Day, April 22 2026
πŸ“… in about 5 hours

ABBN.SW Stock Surges 2.96% on Earnings Day, April 22 2026

ABB Ltd (ABBN.SW) gains 2.96% to CHF76.46 on SIX ahead of earnings announcement. Industrial automation leader shows strong momentum.

Read more
3695.T Stock Gains 1.56% as GMO Product Platform Closes at Β₯1,688
πŸ“… in about 5 hours

3695.T Stock Gains 1.56% as GMO Product Platform Closes at Β₯1,688

3695.T stock rose 1.56% to Β₯1,688 on April 22, 2026. GMO Product Platform trades on JPX with market cap of Β₯7.3B and PE ratio of 39.68.

Read more

MINY News FAQ